serotonin

Small moleculeexperimental

Serotonin, also known as 5-hydroxytryptamine (5-HT), is a monoamine neurotransmitter with a wide range of functions in both the central nervous system (CNS) and also peripheral tissues. It is involved in mood, cognition, reward, learning, memory, and physiological processes such as vomiting and vasoconstriction. In the CNS, serotonin regulates mood, appetite, and sleep. — Wikipedia

Clinical trial activity

3 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1

Earliest trial started May 1, 2005 (NCT00227136)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

NCCc1c[nH]c2ccc(O)cc12
Mol. weight
176.22 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 5-hydroxy-tryptamine
  • 5-hydroxy-tryptamine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06740188Phase 4Jan 1, 2025Huazhong University of Science and Technology
NCT03576053N/AJul 1, 2018Aalborg University
NCT00227136Phase 3May 1, 2005University of Western Ontario
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Aalborg UniversityAcademic/Hospital1112018
Huazhong University of Science and TechnologyAcademic/Hospital1112025
University of Western OntarioAcademic/Hospital1112005
3 organizations
Page 1 / 1